For the longest time, I thought this lyric in The Decemberists' Annan Water was:
"...though my mother cries, that if I try, I sure will drown in pee..."
They repeat it 4 times; the last one, especially, I just can't hear otherwise.
KoboldCoterie
joined 1 year ago
That was my first thought, too - that they'd used Paw Patrol "fan art" as marketing materials, but no... it sounds like it was just improperly vetted adult ads displaying on their site. I am more than a little disappointed.
I mean, if we're going to nitpick, 'lenght' wouldn't be a method. :P
Syntax error: Method 'lenght' not a valid property of 'data'. Relationship over.
It's not a question of not being allowed to produce it, it's anti-competitive practices by the pharmaceuticals industry, which capitalism rewards.
Specifically, drug manufacturers have repeatedly made lots of little changes to their existing insulin products in order to apply for new patents on them. This process, called “evergreening,” has discouraged competitors from developing new versions of existing insulins because they’d have to chase so many changes. This has slowed down innovation, along with “pay for delay” deals, in which insulin manufacturers pay competitors to not copy specific drugs for a period of time.
Even though there are very few insulin products that have patent protection on the compound itself, the vast majority of insulin products still have patent protection on the pens and other devices that deliver the dose of insulin. Novo Nordisk has patents for Novolog, Novolin, and FIASP products; Sanofi has patents on the devices for all of its products; and Eli Lilly still has patents on some devices that deliver Humulin and Humalog.
The patent protection on the devices is significant. Because the pens and other insulin delivery devices can only be used on with one brand of insulin, competition on those products is effectively delayed. While a prospective competitor could develop a follow-on biologic or biosimilar of the insulin, it would have to develop its own delivery device.
Insulin prices in the US is a great example of this. It's not about being competitive, it's about charging the absolute highest amount they can possibly get away with.
The problem is that the biggest "winners" in this case are almost exclusively the people willing to go the furthest to put profits ahead of people, which in a better system would never be incentivized.
I also understand that the “poach police” may intentionally/inadvertently kill innocents with their blanket immunity;
Is there any evidence that that has been happening? (This article is from 2017, and it mentions "more than 20" poachers being killed in 2015, but doesn't mention any non-poachers being killed, which it seems it would have, given it's talking about the downsides.)
While I agree that taking the fight to the people financing the poaching, reducing the number of poachers - and providing a very clear disincentive for other "poor af" hired-guns to take up the mantle - could still help.
Personally, I don't think any implied sanctity of human life extends to people who are killing endangered animals for profit.
I, for one, fully support this development.
This gave me big flashbacks of where I grew up. It was great as a kid, a ton of urban exploration opportunities, but I wouldn't want to live there now.
Also, that “provocative” name is only going to provoke Adobe’s lawyers to send and cease-and-desist lol
Yeah, there's no way this makes it off the ground with that name or those logos. It's clearly designed specifically to be confusable with Adobe which is the most blatant and easily enforceable form of trademark violation out there.
I am happy to have inflicted this on you. ;)